While the prognosis for patients with pleural malignant mesothelioma is poor, certain treatment options can help increase their life expectancy. Surgery combined with chemotherapy is one such treatment option. In most cases, a patient will be diagnosed with the epithelioid cell type, which responds best to cancer treatments. Other types of mesothelioma are classified as biphasic, and respond to treatment differently.
The most common treatment option for pleural mesothelioma is chemotherapy. Chemotherapy is a drug combination that kills cancer cells and prevents them from dividing and replicating. Although the response rate is good with this type of treatment, the success rate is still low. In some cases, a patient may have to undergo another treatment option. HITHOC (heated intrathoracic chemotherapy) is a treatment option for malignant pleural mesotheliomas. This procedure circulates chemotherapy drugs through the chest cavity.
Fortunately, there are many treatment options for malignant pleural mesothelioma. Surgeons and oncologists can use a variety of approaches to help patients fight this disease. Depending on the stage of the cancer, surgery may be the best option for some patients. Sometimes, surgery is not an option. In this case, radiation is the best option. Once the cancer has spread to the lungs, treatment for malignant pleural meso-ma will focus on the cancer cells.
A specialist is the most effective option for treating malignant pleural mesothelioma. In addition to surgery, patients with this disease may need additional treatments. A doctor’s expertise in pleural mesothelio-ma treatment can be very beneficial to a patient’s quality of life. In addition to surgical procedures, patients with this disease can also receive chemotherapy to control the cancer.
Treatment for malignant pleural mesothelioma can be complex. In the meantime, patients must learn as much as they can about the disease and its treatment options. While the disease does not affect the patient’s ability to breathe, he or she should be aware of the severity of the symptoms. If the disease is detected early, the patient can opt for a chemotherapy that will improve the quality of his or her life and reduce pain.
A specialist in malignant pleural mesothelioma is essential for patients suffering from the disease. A specialist can properly diagnose the disease and develop a personalized treatment plan for each patient. In addition to the diagnosis, he or she will also help the patient navigate the treatment options that are available. During the diagnosis process, the doctor will examine the patient’s condition and determine the type of cell in the affected area.
The diagnosis process for malignant pleural mesothelioma starts with the evaluation of the initial symptoms. The symptoms include difficulty breathing and chest pain. A primary care physician will refer the patient to a specialist to determine the cause of the symptoms. During the examination, the doctor will analyze the fluid and perform tissue biopsies in order to confirm the diagnosis. The pathologist will identify the stage and cell type of the cancer.
After the diagnosis of malignant pleural mesothelioma, doctors will use a combination of chemotherapy and surgery. The treatment for malignant pleural mesothimoma focuses on palliative care. Though the median life expectancy is 1-2 years, many patients will live longer than this. The prognosis for a patient with this disease is dependent on the cell type, the stage of the cancer and the overall health of the patient.
In addition to chemotherapy, the most common treatment for malignant pleural mesothelioma is based on surgery. While chemotherapy can improve the prognosis, the success rate is still low. Other treatments are more invasive and involve robotic surgery. A robot is used to deliver a drug to the patient through an incision in the thorax. This type of treatment is also known as peritoneal mesothelioma.
The classic diagnosis of malignant pleural mesothelioma involves a thickening of the lining of the lung by visceral pleura. The peritoneal lining of the lungs is surrounded by a spongy tissue called pleura. These cells are covered with a thin layer of tissue that can cause inflammation and pain. The tumors are often in the lungs, but sometimes they may be found in other parts of the body.